John L. Green - Net Worth and Insider Trading

John L. Green Net Worth

The estimated net worth of John L. Green is at least $28,231 dollars as of 2024-05-14. John L. Green is the CFO of Cogent Biosciences Inc and owns about 3,841 shares of Cogent Biosciences Inc (COGT) stock worth over $28,231. Details can be seen in John L. Green's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John L. Green has not made any transactions after 2021-04-26 and currently still holds the listed stock(s).

Transaction Summary of John L. Green

To

John L. Green Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John L. Green owns 2 companies in total, including Cogent Biosciences Inc (COGT) , and Merrimack Pharmaceuticals Inc (MACK) .

Click here to see the complete history of John L. Green’s form 4 insider trades.

Insider Ownership Summary of John L. Green

Ticker Comapny Transaction Date Type of Owner
COGT Cogent Biosciences Inc 2021-04-26 Chief Financial Officer
MACK Merrimack Pharmaceuticals Inc 2017-06-14 Principal Accounting Officer

John L. Green Latest Holdings Summary

John L. Green currently owns a total of 1 stock. John L. Green owns 3,841 shares of Cogent Biosciences Inc (COGT) as of April 26, 2021, with a value of $28,231.

Latest Holdings of John L. Green

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
COGT Cogent Biosciences Inc 2021-04-26 3,841 7.35 28,231

Holding Weightings of John L. Green


John L. Green Form 4 Trading Tracker

According to the SEC Form 4 filings, John L. Green has made a total of 1 transactions in Cogent Biosciences Inc (COGT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Cogent Biosciences Inc is the sale of 17,813 shares on April 26, 2021, which brought John L. Green around $157,823.

Insider Trading History of John L. Green

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John L. Green Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

John L. Green Ownership Network

Ownership Network List of John L. Green

No Data

Ownership Network Relation of John L. Green


John L. Green Owned Company Details

What does Cogent Biosciences Inc do?

Who are the key executives at Cogent Biosciences Inc?

John L. Green is the Chief Financial Officer of Cogent Biosciences Inc. Other key executives at Cogent Biosciences Inc include 10 percent owner & other: See Remarks Fairmount Funds Management Llc , Chief Legal Officer Evan Kearns , and Chief Scientific Officer John Edward Robinson .

Cogent Biosciences Inc (COGT) Insider Trades Summary

Over the past 18 months, John L. Green made no insider transaction in Cogent Biosciences Inc (COGT). Other recent insider transactions involving Cogent Biosciences Inc (COGT) include a net purchase of 800,000 shares made by Fairmount Funds Management Llc ,

In summary, during the past 3 months, insiders sold 0 shares of Cogent Biosciences Inc (COGT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cogent Biosciences Inc (COGT) were sold and 800,000 shares were bought by its insiders, resulting in a net purchase of 800,000 shares.

Cogent Biosciences Inc (COGT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cogent Biosciences Inc Insider Transactions

No Available Data

John L. Green Mailing Address

Above is the net worth, insider trading, and ownership report for John L. Green. You might contact John L. Green via mailing address: Merrimack Pharmaceuticals, Inc., One Kendall Square, Suite B7201, Cambridge Ma 02139.

Discussions on John L. Green

No discussions yet.